用小分子无药纳米组件进行线粒体重新连接,释放出抗癌免疫力
Lulu Ren1,2, Jianqin Wan1, Xiaoyan Li1,3
1The First Affiliated Hospital, NHC Key Laboratory of Combined Multi-Organ Transplantation, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, PR China.
Nature communications
|September 3, 2024
概括
新的小分子准线粒体,以克服癌症的免疫抑制瘤微环境 (TME),增强免疫检查点阻塞 (ICB) 疗法的有效性. 这种方法可以恢复抗瘤免疫力,从而改善癌症治疗.
科学领域:
- 生物化学 生物化学
- 免疫学 免疫学 免疫学
- 材料科学 材料科学 材料科学
背景情况:
- 免疫抑制性瘤微环境 (TME) 阻碍了有效的癌症控制,并限制了对免疫检查点阻塞 (ICB) 治疗的反应.
- 线粒体是炎症反应和瘤免疫性的关键调节者,使他们成为治疗干预的关键目标.
研究的目的:
- 发现和描述能够自组装成纳米组件的新型小分子.
- 研究这些纳米组件的潜力,以准线粒体,诱导免疫细胞死亡,增强抗瘤免疫力,特别是与ICB疗法结合使用.
主要方法:
- 自组装的小分子形成纳米组件的合成和表征.
- 在体外研究评估线粒体向,内质网膜应激诱导和细胞死亡途径 (亡/亡).
- 在临床前癌症模型中进行的耐PD-1阻塞的体内研究,评估纳米组装和ICB治疗的协同效应.
主要成果:
- 开发的纳米组件有效地向线粒体,诱导细胞内网膜应激,并促进瘤细胞中的免疫细胞死亡.
- 在临床前模型中,纳米组件的局部施用激发了TME,并与ICB疗法协同作用,克服了耐药性并产生了强大的抗瘤免疫力.
- 被治疗的瘤细胞充当了有效的癌症疫苗,引发了预防性和治疗性抗瘤反应.
结论:
- 这种新的纳米组装平台提供了一种有前途的策略,以克服瘤免疫抑制并提高ICB治疗的疗效.
- 小分子免疫增强剂可以动态地调整先天免疫,从而导致无痕迹的癌症治疗.
- 准线粒体功能和诱导免疫细胞死亡是开发下一代癌症免疫疗法的可行方法.
相关概念视频
01:46Electron Transport Chain: Complex I and II
12.3K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
12.3K
01:27Tumor Immunotherapy
493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K